• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睾酮在男性 2 型糖尿病预防和治疗中的作用:关注最近的随机对照试验。

Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials.

机构信息

Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia.

Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia.

出版信息

Ann N Y Acad Sci. 2024 Aug;1538(1):45-55. doi: 10.1111/nyas.15188. Epub 2024 Jul 22.

DOI:10.1111/nyas.15188
PMID:39039746
Abstract

In epidemiological studies, lowered serum testosterone concentrations are common in men with obesity, prediabetes, and established type 2 diabetes (T2D). In men with prediabetes, lowered serum testosterone also predicts a future risk of T2D in men. Administration of testosterone consistently reduces fat mass and increases skeletal muscle mass-body compositional changes expected to be metabolically favorable. In men with established T2D, the effects of testosterone treatment on glycemic measures are inconsistent. Irrespective of baseline serum testosterone concentration in men with prediabetes or newly diagnosed early-onset T2D, testosterone treatment prescribed in conjunction with a lifestyle program has been reported to reduce the risk of T2D by 40% after 2 years, suggesting that either a lifestyle program is required to facilitate the glycemic benefit of testosterone treatment and/or that testosterone treatment has more favorable effects on glycemia in men early in the evolution or onset of the disease. The durability of the benefit and longer-term safety of testosterone treatment have not been established. Therefore, more studies are required before testosterone treatment can be recommended for the prevention and/or treatment of men with or at elevated risk of T2D who do not have hypogonadism due to an established disease of the hypothalamic-pituitary-testicular axis.

摘要

在流行病学研究中,肥胖、糖尿病前期和已确诊的 2 型糖尿病(T2D)患者的血清睾丸酮浓度往往较低。在糖尿病前期患者中,血清睾丸酮降低也预示着未来男性患 T2D 的风险。睾丸酮的应用可持续降低脂肪量,增加骨骼肌量——这是预期对代谢有益的身体成分变化。对于已确诊的 T2D 患者,睾丸酮治疗对血糖指标的影响并不一致。无论糖尿病前期或新诊断的早发性 T2D 患者的基线血清睾丸酮浓度如何,联合生活方式方案进行的睾丸酮治疗报告显示,可在 2 年内降低 40%的 T2D 风险,这表明生活方式方案有助于促进睾丸酮治疗的血糖益处,和/或睾丸酮治疗对疾病早期或发病时的男性血糖有更有利的影响。睾丸酮治疗的获益持续时间和长期安全性尚未确定。因此,在推荐睾丸酮治疗用于预防和/或治疗因下丘脑-垂体-睾丸轴的既定疾病而无性腺功能减退症的 T2D 患者或处于 T2D 风险升高的男性之前,还需要进行更多的研究。

相似文献

1
Testosterone in prevention and treatment of type 2 diabetes in men: Focus on recent randomized controlled trials.睾酮在男性 2 型糖尿病预防和治疗中的作用:关注最近的随机对照试验。
Ann N Y Acad Sci. 2024 Aug;1538(1):45-55. doi: 10.1111/nyas.15188. Epub 2024 Jul 22.
2
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.男性性腺功能减退症患者的睾酮治疗可预防从糖尿病前期进展为 2 型糖尿病:来自注册研究的八年数据。
Diabetes Care. 2019 Jun;42(6):1104-1111. doi: 10.2337/dc18-2388. Epub 2019 Mar 12.
3
Testosterone deficiency in men with Type 2 diabetes: pathophysiology and treatment.2 型糖尿病男性的睾酮缺乏:病理生理学和治疗。
Diabet Med. 2020 Feb;37(2):174-186. doi: 10.1111/dme.13977. Epub 2019 Jun 4.
4
Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.2型糖尿病男性患者的睾酮治疗——一项随机、双盲、安慰剂对照研究。
Dan Med J. 2017 Jul;64(7).
5
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.生活方式干预项目中纳入的男性接受睾酮治疗以预防或逆转 2 型糖尿病(T4DM):一项随机、双盲、安慰剂对照、为期 2 年的 3b 期试验。
Lancet Diabetes Endocrinol. 2021 Jan;9(1):32-45. doi: 10.1016/S2213-8587(20)30367-3.
6
Late-onset hypogonadism: metabolic impact.迟发性性腺功能减退症:代谢影响。
Andrology. 2020 Nov;8(6):1519-1529. doi: 10.1111/andr.12705. Epub 2019 Sep 25.
7
Effect of Testosterone on Progression From Prediabetes to Diabetes in Men With Hypogonadism: A Substudy of the TRAVERSE Randomized Clinical Trial.雄激素缺乏症男性患者从糖尿病前期进展至糖尿病的影响:TRAVERSE 随机临床试验的一项子研究。
JAMA Intern Med. 2024 Apr 1;184(4):353-362. doi: 10.1001/jamainternmed.2023.7862.
8
Testosterone therapy in older men: clinical implications of recent landmark trials.老年男性睾酮治疗:近期里程碑式试验的临床意义。
Eur J Endocrinol. 2024 Jul 2;191(1):R22-R31. doi: 10.1093/ejendo/lvae071.
9
Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosterone.睾酮治疗男性低睾酮水平的 2 型糖尿病预防和逆转。
Curr Opin Pharmacol. 2021 Jun;58:83-89. doi: 10.1016/j.coph.2021.04.002. Epub 2021 May 13.
10
Effects of androgens on glucose metabolism.雄激素对葡萄糖代谢的影响。
Best Pract Res Clin Endocrinol Metab. 2022 Sep;36(5):101654. doi: 10.1016/j.beem.2022.101654. Epub 2022 Mar 31.

引用本文的文献

1
TESTOSTERONE AND INSULIN RESISTANCE IN MEN: EVIDENCE FOR A COMPLEX BI-DIRECTIONAL RELATIONSHIP.男性体内的睾酮与胰岛素抵抗:复杂双向关系的证据
Trans Am Clin Climatol Assoc. 2025;135:297-305.
2
Association between waist-to-hip ratio and testosterone in Chinese men with young-onset type 2 diabetes: a cross-sectional study.中国青年2型糖尿病男性患者腰臀比与睾酮水平的相关性:一项横断面研究
BMC Endocr Disord. 2025 Mar 6;25(1):60. doi: 10.1186/s12902-025-01832-4.